DHC Organization

1. Organization DHC
2. Organization Nursing Symposium
3. DHC Foundation
4. HOVON Foundation
5. NVvH 

1. Organization DHC
A project team, especially put together for DHC, is responsible for the overall organisation of the congress. The team plays an important role in optimizing communication and co-operation between all parties that are involved with this event.

Project team

The Program Committee is responsible for composing the program and inviting the speakers. This Program Committee consists of representatives from HOVON, NVvH, Experimental Hematology, KWF Lymphoma group, stem cell transplantation group, and the fellows. Key persons are appointed to select the speakers for the fundamental and translational research sessions. 

Program committee:
Dr. Suzanne van Dorp (chair)
Dr. Laura van Hussen-Daenen (vice-chair)

Members of the Program Committee 

Klinisch
Dr. Canan Alhan
Dr. Roel Fiets
Dr. Claudia Ootjers
Dr. Hilde Kooistra
Dr. Bas Blok en dr. Inge Geelen (JNVvH)
Dr. Sarah Schep
Dr. Josien Regelink
Dr. Laurens Nieuwenhuizen
Dr. Astrid Pulles
Dr. Vera Novotny
Lymfoproliferatieve ziekten
Dr. Wouter Plattel
Dr. Eric Eldering
Dr. Joost Vermaat
Dr. Marjolein van der Poel
Transplantatie en Immunologie
Dr. Lotte van der Wagen
Dr. Anoek Broers
Dr. Mieke Roeven
Dr. Rosa de Groot
Hematopoiese en Leukemie
Dr. Vincent van den Boom
Dr. Jurjen Versluis
Dr. Mirjam Belderbos
Dr. Emile van den Akker
VHL
Dr. Mathie Leers

 
Key persons

The national key persons will closely and actively collaborate with group leaders of relevant Dutch research centers (academic hospitals, Sanquin and IKNL) in selecting presentations on subjects within their field of expertise. With this approach it is expected to come to a better representation of the current fundamental and translational research in the field of (immuno)hematology in the Netherlands. Do you have any suggestion for presentations in one of the research fields and you have not been contacted by one of the national key persons or group leaders, you may contact one of the keypersons for that field.

Executive team
During the congress, an executive team is present to assist you. The executive team consists of: Regina Knoester (Project Manager), Saskia Broekman (sponsorship), Susanne Højsgaard-Tabbers, Tamara van Rijswijk and Mirelle Meevis.

2. Organization Nursing Symposium                                                                                               to the top

The program committee is responsible for the composition of the program of the Nursing Symposium and the invitation of speakers. This program committee has been put together by representatives of the Tumor Working Group Hematology, V&VN Oncology. 

Tumor Werk Groep Hematologie, V&VN Oncologie
email: twghematologieoncologie@venvn.nl
website: Tumor Werk Groep Hematologie V&VN

Program committee

• Shahira Fazel - Radboudumc - Nijmegen - Chair
• Judith van Deursen - Maxima Medisch Centrum - Veldhoven 
• Linda Luppens-de Graaf - Dijklander ziekenhuis - Hoorn
• Jacqueline Wellenberg-Tielbeke - Isala - Zwolle
• Mirjam Oudshoorn - LUMC - Leiden
• Maaike de Ruijter - Amsterdam UMC, location VUmc - Amsterdam

For questions, please contact the chair of the program committe Shahira Fazel:Shahira.Fazel@radboudumc.nl 

3. DHC Foundation                                                                                                                                 to the top

Since August 2017, the congress activities of the HOVON Foundation and the NVvH are merged into the DHC Foundation. The main reason for the establishment of this foundation, is to provide transparancy in both activities and financial flows. The members of the board of the DHC Foundation are:

4. HOVON Foundation                                                                                                                            to the top

On October 1, 1985, six prominent internists, hematologists from different academic hospitals, founded the HOVON Foundation (Hemato-oncology for Adults the Netherlands) in Rotterdam. HOVON aims to promote 'the optimal treatment of adult patients with haematological malignant diseases'. The best way to obtain this optimal treatment is through the creation and implementation of clinical studies in which as many patients as possible are able to participate.
Because hemato-oncological diseases are rare in terms of frequency, it is necessary to make the required expertise for treatment quickly available to patients. This is realised by creating and managing networks of doctors in various hospitals.
For further information on the HOVON Foundation, visit the website.

5. Dutch Society of Hematology (NVvH)                                                                                                  to the top

The Dutch Society of Hematology (NVvH), founded in 1950, is the national organization of blood experts. Around 440 doctors and biomedical scientists working in the field of patient care, research and education of diseases of the blood and blood-forming tissues.
The NVvH has a co-ordinating role and is an umbrella organization for associations operating in the different areas of hematology. This coordinating role improves the position of hematology as to patient care, education and research, and prevents fragmentation of Dutch hematology.
A close co-operation exists with the sub- and sister organizations, including representation in the board of the NVvH, and by organizing joint meetings.
For further information about the Dutch Society of Hematology (NVvH), visit the website.